Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Lupus Nephritis (LN): early-phase trial registry
3 of 3 indexed Lupus Nephritis (LN) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 3 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Lupus Nephritis (LN): 3 US clinical trials tracked, 3 recruiting.
Lupus Nephritis (LN) is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Lupus Foundation of America, running 1 of these trials.
Enrollment posture brief
Registry condition lupus-nephritis-ln
OPEN 3 | RECR 100% | LATE 0 | EARLY 2 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Lupus Nephritis (LN) lists 3 open slots (100% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Lupus Nephritis (LN) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Lupus Nephritis (LN) is recruiting above its size-band peers.
3 of 3 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Research Accelerated by You Lupus Registry
Lupus Foundation of America
NCT06927219
Safety and Efficacy of ONT01 in Lupus
Hospital for Special Surgery, New York
NCT07107659
CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
Children's Hospital of Philadelphia
NCT06839976
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Lupus Nephritis (LN) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Lupus Nephritis (LN) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Lupus Nephritis (LN) page
3 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Lupus Nephritis (LN) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Lupus Foundation of America sponsors the most Lupus Nephritis (LN) trials on record, review their full trial history before evaluating a specific study. See Lupus Foundation of America's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Lupus Nephritis (LN) condition card totals 3 registered trials; most-linked intervention ONT01 is a small molecule CD11b modulator.; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.